• Something wrong with this record ?

The role of colonization with resistant Gram-negative bacteria in the treatment of febrile neutropenia after stem cell transplantation

T. Sokolová, P. Paterová, A. Zavřelová, B. Víšek, P. Žák, J. Radocha

. 2024 ; 153 (-) : 73-80. [pub] 20240912

Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Febrile neutropenia (FN) is a common complication of stem cell transplantation. AIM: To evaluate the frequency of sepsis in patients with FN colonized with resistant Gram-negative bacteria (extended-spectrum β-lactamase (ESBL)-positive, multidrug-resistant (MDR) Pseudomonas aeruginosa) and the choice of primary antibiotic in colonized patients. METHODS: This retrospective study analysed data from patients undergoing haematopoietic stem cell transplantation from January 2018 to September 2022. Data were extracted from the hospital information system. FINDINGS: Carbapenem as the primary antibiotic of choice was chosen in 10.9% of non-colonized +/-AmpC patients, 31.5% of ESBL+ patients, and 0% of MDR P. aeruginosa patients. Patients with FN and MDR P. aeruginosa colonization had a high prevalence of sepsis (namely 100%, P = 0.0197). The spectrum of sepsis appeared to be different, with Gram-negative bacilli predominating in the ESBL+ group (OR: 5.39; 95% CI: 1.55-18.76; P = 0.0123). Colonizer sepsis was present in 100% of sepsis with MDR P. aeruginosa colonization (P = 0.002), all in allogeneic transplantation (P = 0.0003), with a mortality rate of 33.3% (P = 0.0384). The incidence of sepsis in patients with ESBL+ colonization was 25.9% (P = 0.0197), with colonizer sepsis in 50% of sepsis cases (P = 0.0002), most in allogeneic transplantation (P = 0.0003). CONCLUSION: The results show a significant risk of sepsis in FN with MDR P. aeruginosa colonization, a condition almost exclusively caused by the colonizer. At the same time, a higher risk of Gram-negative sepsis has been demonstrated in patients colonized with ESBL+ bacteria.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003650
003      
CZ-PrNML
005      
20250206104602.0
007      
ta
008      
250121e20240912enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jhin.2024.08.012 $2 doi
035    __
$a (PubMed)39277087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sokolová, T $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
245    14
$a The role of colonization with resistant Gram-negative bacteria in the treatment of febrile neutropenia after stem cell transplantation / $c T. Sokolová, P. Paterová, A. Zavřelová, B. Víšek, P. Žák, J. Radocha
520    9_
$a BACKGROUND: Febrile neutropenia (FN) is a common complication of stem cell transplantation. AIM: To evaluate the frequency of sepsis in patients with FN colonized with resistant Gram-negative bacteria (extended-spectrum β-lactamase (ESBL)-positive, multidrug-resistant (MDR) Pseudomonas aeruginosa) and the choice of primary antibiotic in colonized patients. METHODS: This retrospective study analysed data from patients undergoing haematopoietic stem cell transplantation from January 2018 to September 2022. Data were extracted from the hospital information system. FINDINGS: Carbapenem as the primary antibiotic of choice was chosen in 10.9% of non-colonized +/-AmpC patients, 31.5% of ESBL+ patients, and 0% of MDR P. aeruginosa patients. Patients with FN and MDR P. aeruginosa colonization had a high prevalence of sepsis (namely 100%, P = 0.0197). The spectrum of sepsis appeared to be different, with Gram-negative bacilli predominating in the ESBL+ group (OR: 5.39; 95% CI: 1.55-18.76; P = 0.0123). Colonizer sepsis was present in 100% of sepsis with MDR P. aeruginosa colonization (P = 0.002), all in allogeneic transplantation (P = 0.0003), with a mortality rate of 33.3% (P = 0.0384). The incidence of sepsis in patients with ESBL+ colonization was 25.9% (P = 0.0197), with colonizer sepsis in 50% of sepsis cases (P = 0.0002), most in allogeneic transplantation (P = 0.0003). CONCLUSION: The results show a significant risk of sepsis in FN with MDR P. aeruginosa colonization, a condition almost exclusively caused by the colonizer. At the same time, a higher risk of Gram-negative sepsis has been demonstrated in patients colonized with ESBL+ bacteria.
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a febrilní neutropenie $x mikrobiologie $7 D064147
650    _2
$a dospělí $7 D000328
650    12
$a gramnegativní bakterie $x účinky léků $x izolace a purifikace $7 D006090
650    12
$a antibakteriální látky $x terapeutické užití $7 D000900
650    12
$a gramnegativní bakteriální infekce $x farmakoterapie $x epidemiologie $7 D016905
650    _2
$a senioři $7 D000368
650    _2
$a sepse $x mikrobiologie $7 D018805
650    _2
$a mladý dospělý $7 D055815
650    _2
$a transplantace hematopoetických kmenových buněk $x škodlivé účinky $7 D018380
650    _2
$a mladiství $7 D000293
650    _2
$a mnohočetná bakteriální léková rezistence $7 D024901
650    _2
$a přenašečství $x mikrobiologie $x epidemiologie $7 D002353
655    _2
$a časopisecké články $7 D016428
700    1_
$a Paterová, P $u Department of Clinical Microbiology, Hradec Králové University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Zavřelová, A $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Víšek, B $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Žák, P $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Radocha, J $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czechia; Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czechia. Electronic address: radochaj@lfhk.cuni.cz
773    0_
$w MED00002716 $t The Journal of hospital infection $x 1532-2939 $g Roč. 153 (20240912), s. 73-80
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39277087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104557 $b ABA008
999    __
$a ok $b bmc $g 2263418 $s 1239657
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 153 $c - $d 73-80 $e 20240912 $i 1532-2939 $m The Journal of hospital infection $n J Hosp Infect $x MED00002716
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...